Cargando…
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses
AIMS/HYPOTHESIS: Galectin-1 modulates inflammation and angiogenesis, and cross-sectional studies indicate that galectin-1 may be a uniting factor between obesity, type 2 diabetes and kidney function. We examined whether circulating galectin-1 can predict incidence of chronic kidney disease (CKD) and...
Autores principales: | Drake, Isabel, Fryk, Emanuel, Strindberg, Lena, Lundqvist, Annika, Rosengren, Anders H., Groop, Leif, Ahlqvist, Emma, Borén, Jan, Orho-Melander, Marju, Jansson, Per-Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660752/ https://www.ncbi.nlm.nih.gov/pubmed/34743218 http://dx.doi.org/10.1007/s00125-021-05594-1 |
Ejemplares similares
-
Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study()
por: Fryk, Emanuel, et al.
Publicado: (2019) -
Galectin-1 in Obesity and Type 2 Diabetes
por: Fryk, Emanuel, et al.
Publicado: (2022) -
New Insights into Impaired Muscle Glycogen Synthesis: More a Problem of Muscle Contractility Than of Glucose Tolerance
por: Groop, Leif, et al.
Publicado: (2008) -
Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial
por: Fryk, Emanuel, et al.
Publicado: (2023) -
The insertion/deletion variation in the α(2B)-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes
por: Snapir, Amir, et al.
Publicado: (2003)